These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 7527374
1. Therapy for hepatitis B virus infection. Perrillo RP, Mason AL. Gastroenterol Clin North Am; 1994 Sep; 23(3):581-601. PubMed ID: 7527374 [Abstract] [Full Text] [Related]
2. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up. Zavaglia C, Bottelli R, Bellati G, Asti L, Mondazzi L, Iamoni G, Zanetti A, Tanzi E, Fesce E, Gelosa F, Maggi G, Ideo G. Ital J Gastroenterol; 1996 Sep; 28(6):324-31. PubMed ID: 8891847 [Abstract] [Full Text] [Related]
3. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels. Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C. Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116 [Abstract] [Full Text] [Related]
4. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T. Hepatogastroenterology; 1998 Mar; 45(24):2282-94. PubMed ID: 9951911 [Abstract] [Full Text] [Related]
5. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection. Bozkaya H, Ayola B, Lok AS. Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278 [Abstract] [Full Text] [Related]
6. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study. Serfaty L, Thabut D, Zoulim F, Andreani T, Chazouillères O, Carbonell N, Loria A, Poupon R. Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544 [Abstract] [Full Text] [Related]
7. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up]. Liu DL, Luo KX, Feng XR, Fu QX, Hou JL. Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996 [Abstract] [Full Text] [Related]
8. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B. Zhang X, Zoulim F, Habersetzer F, Xiong S, Trépo C. J Med Virol; 1996 Jan 10; 48(1):8-16. PubMed ID: 8825704 [Abstract] [Full Text] [Related]
9. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C. Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T. Int J Mol Med; 2002 Aug 10; 10(2):201-4. PubMed ID: 12119559 [Abstract] [Full Text] [Related]
10. [The combined treatment with prednisolone and recombinant alpha 2-interferon of patients with chronic hepatitis B: the factors influencing the immune response]. Fedorchenko SV, Vovk AD, Rybalko SL. Ter Arkh; 1994 Aug 10; 66(2):24-9. PubMed ID: 8160138 [Abstract] [Full Text] [Related]
11. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients. Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC. Am J Gastroenterol; 2005 Nov 10; 100(11):2463-71. PubMed ID: 16279901 [Abstract] [Full Text] [Related]
12. Therapy of acute and chronic viral hepatitis. Hoofnagle JH. Adv Intern Med; 1994 Nov 10; 39():241-75. PubMed ID: 8140956 [Abstract] [Full Text] [Related]
13. The long-term course of chronic hepatitis B. Di Marco V, Lo Iacono O, Cammà C, Vaccaro A, Giunta M, Martorana G, Fuschi P, Almasio PL, Craxì A. Hepatology; 1999 Jul 10; 30(1):257-64. PubMed ID: 10385664 [Abstract] [Full Text] [Related]
14. Pilot study of ribavirin and interferon-beta for chronic hepatitis B. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. Hepatology; 1993 Aug 10; 18(2):258-63. PubMed ID: 8340055 [Abstract] [Full Text] [Related]
15. Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon. Hartman C, Berkowitz D, Shouval D, Eshach-Adiv O, Hino B, Rimon N, Satinger I, Kra-Oz T, Daudi N, Shamir R. Pediatr Infect Dis J; 2003 Mar 10; 22(3):224-9. PubMed ID: 12634582 [Abstract] [Full Text] [Related]
16. Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy. El-Zayadi AR, Badran HM, Saied A, Shawky S, Attia Mel-D, Zalata K. Am J Gastroenterol; 2009 Apr 10; 104(4):906-11. PubMed ID: 19293791 [Abstract] [Full Text] [Related]
17. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Mommeja-Marin H, Mondou E, Blum MR, Rousseau F. Hepatology; 2003 Jun 10; 37(6):1309-19. PubMed ID: 12774009 [Abstract] [Full Text] [Related]
18. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis. Buti M, Jardi R, Rodriguez-Frias F, Allende H, Cotrina M, Esteban R, Guardia J. J Med Virol; 1996 Aug 10; 49(4):325-8. PubMed ID: 8877766 [Abstract] [Full Text] [Related]
19. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial. Janssen HL, Berk L, Heijtink RA, ten Kate FJ, Schalm SW. Hepatology; 1993 Mar 10; 17(3):383-8. PubMed ID: 8444411 [Abstract] [Full Text] [Related]
20. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha. van der Eijk AA, Niesters HG, Hansen BE, Heijtink RA, Janssen HL, Schalm SW, de Man RA. J Viral Hepat; 2006 Feb 10; 13(2):96-103. PubMed ID: 16436127 [Abstract] [Full Text] [Related] Page: [Next] [New Search]